Design of a Human Defensin 5-Derived Linear Peptide with Potent Antibacterial Efficacy Against Carbapenem-Resistant Acinetobacter baumannii
Molecules · 2026
DOI: 10.3390/molecules31213885 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2026. Verfasst von Gaomei Zhao und 11 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Trauma and Chemical Poisoning, Institute of Combined Injury of PLA, College of Preventive Medicine, Army Medical University, …. Hauptthemen laut MEDLINE: Acinetobacter baumannii, Anti-Bacterial Agents, Carbapenems, Acinetobacter Infections. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Chongqing Talent Program, National Natural Science Foundation of China.
Abstract (Originalsprache)
The increasing incidence of infections caused by carbapenem-resistant Acinetobacter baumannii (CRAB) poses a serious threat to global public health, yet treatment options remain scarce. Human defensins (HDs) represent a promising alternative to conventional antibiotics for combating superbugs; however, their structural complexity often hinders synthetic accessibility. Here, we report the rational design of HD5lp5, a linear peptide derived from HD5 through the removal of disulfide bonds and the introduction of arginine residues. This derivative exhibits potent bactericidal activity against CRAB and retains bioactivity in complex physiological environments. Mechanistically, HD5lp5 binds to bacterial lipid A with a dissociation constant of 1.81 nM and destroys membrane integrity in a dose-dependent manner, inducing the leakage of intracellular contents. Beyond membrane disruption, its structural flexibility enables translocation into bacteria. In vitro translation assay reveals that HD5lp5 inhibits ribosomal translation with a half-maximal inhibitory concentration of 0.38 μM. Notably, HD5lp5 exhibits no apparent toxicity in vivo, and it effectively eliminates CRAB colonisation in murine models of intra-abdominal sepsis and irradiation-assisted pulmonary infection, thereby increasing survival rates. Our findings establish HD5lp5 as a promising preclinical candidate for treating life-threatening CRAB.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Trauma and Chemical Poisoning, Institute of Combined Injury of PLA, College of Preventive Medicine, Army Medical University, Chongqing 400038, China.
- College of Basic Medicine, Army Medical University, Chongqing 400038, China.
ORCID-Profile: Cheng Wang
Förderung
- Chongqing Talent Program
- National Natural Science Foundation of China
Zitieren
APA
Zhao, G., Tan, C., Li, X., Li, C., Shu, M., Wang, C., Quan, K., He, Y., Gao, J., Han, S., Wang, J., & Wang, C. (2026). Design of a Human Defensin 5-Derived Linear Peptide with Potent Antibacterial Efficacy Against Carbapenem-Resistant Acinetobacter baumannii. Molecules. https://doi.org/10.3390/molecules31213885
Vancouver
Zhao G, Tan C, Li X, Li C, Shu M, Wang C, et al. Design of a Human Defensin 5-Derived Linear Peptide with Potent Antibacterial Efficacy Against Carbapenem-Resistant Acinetobacter baumannii. Molecules. 2026. doi:10.3390/molecules31213885
BibTeX
@article{Zhao2026,
author = {Zhao, Gaomei and Tan, Chengzhang and Li, Xin and Li, Chenwenya and Shu, Mingrui and Wang, Chao and Quan, Kainuo and He, Yongwu and Gao, Jining and Han, Songling and Wang, Junping and Wang, Cheng},
title = {Design of a Human Defensin 5-Derived Linear Peptide with Potent Antibacterial Efficacy Against Carbapenem-Resistant Acinetobacter baumannii},
journal = {Molecules},
year = {2026},
doi = {10.3390/molecules31213885}
}
EUVIMED